GR
GONZALEZ RICHARD A Chairman & CEO
C-suite M
Insider track record CEO Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by GONZALEZ RICHARD A, Chairman & CEO. Officer active across 1 company, notably AbbVie Inc.. Aggregated, 27 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €13.8m. Activity tracked since 9 December 2021. The latest transaction was filed on 31 March 2025 (Don). Regulator: SEC (Form 4). The full history is openly available.
Declarations 27 total
2,450 shares 0Common Stock, $0.01 par value SEC:0001415889-25-009688:0
73,209 shares @ US$205.02 16.6% of flow Common Stock, $0.01 par value SEC:0001415889-25-006579:0
80,945 shares 0Common Stock, $0.01 par value SEC:0001415889-25-004455:0
33,208 shares 0Common Stock, $0.01 par value SEC:0001415889-25-004455:1
30,298 shares 0Common Stock, $0.01 par value SEC:0001415889-25-004455:2
27,386 shares 0Common Stock, $0.01 par value SEC:0001415889-25-004455:3
● EXECUTIVE CHAIRMAN OF BOARD · Executives · 30 Sept 2024 · AbbVie Inc. 5,243 shares 0Common Stock, $0.01 par value SEC:0001415889-24-024451:0
▼ EXECUTIVE CHAIRMAN OF BOARD · Executives · 5 Aug 2024 · AbbVie Inc. 66,500 shares @ US$186.52 13.1% of flow Common Stock, $0.01 par value SEC:0001415889-24-020926:0
◇ EXECUTIVE CHAIRMAN OF BOARD · Executives · 17 Jul 2024 · AbbVie Inc. 87,050 shares @ US$61.36 5.6% of flow Common Stock, $0.01 par value SEC:0000897069-24-001526:0
● CHAIRMAN OF THE BOARD AND CEO · Executives · 28 Jun 2024 · AbbVie Inc. 6,000 shares 0Common Stock, $0.01 par value SEC:0000897069-24-001469:0
● CHAIRMAN OF THE BOARD AND CEO · Executives · 28 Feb 2024 · AbbVie Inc. 110,249 shares @ US$178.99 21.0% of flow Common Stock, $0.01 par value SEC:0001415889-24-006155:0
● CHAIRMAN OF THE BOARD AND CEO · Executives · 27 Feb 2024 · AbbVie Inc. 1,670 shares 0Common Stock, $0.01 par value SEC:0001415889-24-005915:0
◆ CHAIRMAN OF THE BOARD AND CEO · Executives · 15 Feb 2024 · AbbVie Inc. 146,335 shares 0Common Stock, $0.01 par value SEC:0001415889-24-004415:0
◆ CHAIRMAN OF THE BOARD AND CEO · Executives · 15 Feb 2024 · AbbVie Inc. 39,022 shares 0Common Stock, $0.01 par value SEC:0001415889-24-004415:1
◆ CHAIRMAN OF THE BOARD AND CEO · Executives · 15 Feb 2024 · AbbVie Inc. 33,208 shares 0Common Stock, $0.01 par value SEC:0001415889-24-004415:2
◆ CHAIRMAN OF THE BOARD AND CEO · Executives · 15 Feb 2024 · AbbVie Inc. 30,300 shares 0Common Stock, $0.01 par value SEC:0001415889-24-004415:3
● CHAIRMAN OF THE BOARD AND CEO · Executives · 25 Sept 2023 · AbbVie Inc. 42,000 shares 0Common Stock, $0.01 par value SEC:0001415889-23-013605:0
▼ CHAIRMAN OF THE BOARD AND CEO · Executives · 31 Jul 2023 · AbbVie Inc. 18,500 shares @ US$149.15 2.9% of flow Common Stock, $0.01 par value SEC:0001415889-23-011768:0
● CHAIRMAN OF THE BOARD AND CEO · Executives · 3 Mar 2023 · AbbVie Inc. 2,550 shares 0Common Stock, $0.01 par value SEC:0001415889-23-004429:0
● CHAIRMAN OF THE BOARD AND CEO · Executives · 28 Feb 2023 · AbbVie Inc. 113,810 shares @ US$154.28 19.1% of flow Common Stock, $0.01 par value SEC:0001415889-23-003822:0
◆ CHAIRMAN OF THE BOARD AND CEO · Executives · 16 Feb 2023 · AbbVie Inc. 149,732 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002939:0
◆ CHAIRMAN OF THE BOARD AND CEO · Executives · 16 Feb 2023 · AbbVie Inc. 34,937 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002939:1
◆ CHAIRMAN OF THE BOARD AND CEO · Executives · 16 Feb 2023 · AbbVie Inc. 39,022 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002939:2
◆ CHAIRMAN OF THE BOARD AND CEO · Executives · 16 Feb 2023 · AbbVie Inc. 33,210 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002939:3
● Chairman of the Board and CEO · Executives · 24 Feb 2022 · AbbVie Inc. 2,610 shares 0Common Stock, $0.01 par value SEC:0001179110-22-001825:0
25 of 27 declarations
Load more (2 remaining) About GONZALEZ RICHARD A Richard A. Gonzalez is the Chairman & CEO of AbbVie Inc. He leads the company in its efforts to develop innovative treatments and improve patient health worldwide. His leadership is crucial for AbbVie's growth strategy and overall performance.